Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876273 · ClinicalTrials.gov registry record · NA
Neural-net Artificial Pancreas (NAP)
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05876273 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 15 participants.
The verdict
NCT05876273, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is intended to assess a Neural-net Artificial Pancreas (NAP) implementation of an established AP controller - the University of Virginia Model Predictive Control Algorithm (UMPC). The health outcomes achieved on NAP will be compared to the health outcomes achieved on UMPC in a randomized crossover design. The investigators will consent up to 20 participants, ages ≥18.0, with a goal of completing 15 participants.
Interventions
- DEVICE Neural-net Artificial Pancreas
- DEVICE University of Virginia Model Predictive Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2023-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05876273
The ClinicalTrials.gov registry entry for NCT05876273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neural-net Artificial Pancreas is the first listed.
NCT05876273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05876273 about?
NCT05876273 is a clinical study titled "Neural-net Artificial Pancreas (NAP)". This study is intended to assess a Neural-net Artificial Pancreas (NAP) implementation of an established AP controller - the University of Virginia Model Predictive Control Algorithm (UMPC). The health outcomes achieved on NAP will be compared to the health outcomes achieved on UMPC in a randomized ...
What is the current status of trial NCT05876273?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-05-30. Estimated completion is 2023-09-10.
What interventions are being tested in trial NCT05876273?
The interventions under investigation include: Neural-net Artificial Pancreas (DEVICE), University of Virginia Model Predictive Control (DEVICE).
Who is sponsoring clinical trial NCT05876273?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.